Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances sorted by
relevance

Admin29.09.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

51010
Admin12.09.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

305
Admin21.09.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

1807
Admin15.09.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

4702
Admin20.07.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

9009
Admin05.08.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

4500
Admin20.09.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

7005
Admin27.07.2021

Co-administration of the mTORC1/TORC2 inhibitor INK128 and

8305
Admin02.10.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

7808
Admin17.07.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

2904
Admin01.09.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

3503
Admin07.10.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

9302
Admin09.09.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

2600
Admin21.09.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

5305
Admin21.08.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

Admin31.08.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

1602
Admin31.08.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

7307
Admin29.09.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

6902
Admin22.07.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

5402
Admin14.07.2021

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances

Admin16.08.2021

Bcl-2/Bcl-xL dual knockdown strikingly enhances anti-tumor

6300